載入...
Watching the clock in glioblastoma
Glioblastoma (GBM) is the most prevalent malignant primary brain tumor, accounting for 14.2% of all diagnosed tumors and 50.1% of all malignant tumors, and the median survival time is approximately 8 months irrespective of whether a patient receives treatment without significant improvement despite...
Autores principales: | , , |
---|---|
格式: | Online Artículo Texto |
語言: | English |
出版: |
Oxford University Press
2023
|
主題: | |
在線閱讀: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628946/ https://www.ncbi.nlm.nih.gov/pubmed/37326042 http://dx.doi.org/10.1093/neuonc/noad107 |